Skip to main content
. 2019 Apr 17;25(3):e153–e158. doi: 10.1111/hae.13751

Table 4.

Range of pharmacokinetic variables in Asian and non‐Asian patients in the LEOPOLD clinical trials

  Asiana (n = 10) Non‐Asian (n = 32)
AUCnorm, kg/h/dL 22.1‐50.7 13.5‐68.2
Cmax, norm, kg/dL 1.2‐3.6 0.9‐3.5
Half‐life, h 9.6‐23.7 7.7‐18.8

AUCnorm, dose‐normalized area under the curve; Cmax, norm, dose‐normalized maximum concentration.

a

Includes six Chinese patients.